CITIGROUP INC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,729,124
-27.3%
176,896
+74.1%
0.01%
-16.7%
Q2 2023$9,254,394
-19.0%
101,585
-41.4%
0.01%
-25.0%
Q1 2023$11,424,733
+68.0%
173,207
+31.7%
0.01%
+60.0%
Q4 2022$6,799,865
-40.7%
131,500
-21.6%
0.01%
-44.4%
Q3 2022$11,464,000
+135.7%
167,832
+56.0%
0.01%
+200.0%
Q2 2022$4,864,000
+146.2%
107,560
+176.6%
0.00%
+200.0%
Q1 2022$1,976,000
-65.1%
38,884
-67.5%
0.00%
-66.7%
Q4 2021$5,659,000
+144.2%
119,688
+70.3%
0.00%
+200.0%
Q3 2021$2,317,000
-60.5%
70,292
-24.2%
0.00%
-75.0%
Q2 2021$5,860,000
+39.3%
92,728
-5.5%
0.00%
+33.3%
Q1 2021$4,208,000
-22.7%
98,074
+3.0%
0.00%0.0%
Q4 2020$5,445,000
+1858.6%
95,186
+933.8%
0.00%
Q3 2020$278,000
-87.4%
9,207
-86.4%
0.00%
-100.0%
Q2 2020$2,214,000
+57.6%
67,785
+29.2%
0.00%
+100.0%
Q1 2020$1,405,000
-43.4%
52,449
-35.3%
0.00%
-50.0%
Q4 2019$2,481,000
+186.8%
81,036
+125.6%
0.00%
+100.0%
Q3 2019$865,000
-27.4%
35,923
-23.6%
0.00%0.0%
Q2 2019$1,191,000
+160.0%
47,022
+100.3%
0.00%
Q1 2019$458,000
-31.8%
23,475
-53.9%
0.00%
-100.0%
Q4 2018$672,000
-20.5%
50,913
+7.1%
0.00%0.0%
Q3 2018$845,000
+41.1%
47,527
+74.6%
0.00%0.0%
Q2 2018$599,00027,226
+136030.0%
0.00%
Q1 2018$0
-100.0%
20
-98.4%
0.00%
Q4 2017$26,0001,2200.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders